Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Mark M. Dermot DurcanIndependent Chairman of the Board | 4,00k | 1,07M | Achat | 266,26 | 26,86k | 17,50% |
| 2026-03-11 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | 4,74k | 0,00 | Derivative Exercise and Retained Stock | - | 23,57k | 25,19% |
| 2026-03-11 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -3,67k | 1,29M | Derivative Exercise and Sale | 350,30 | 23,57k | - |
| 2026-03-11 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | 6,78k | 0,00 | Derivative Exercise and Retained Stock | - | 30,71k | 28,34% |
| 2026-03-11 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -5,84k | 2,05M | Derivative Exercise and Sale | 350,30 | 30,71k | - |
| 2026-03-11 | Mr. James F. ClearyExec. VP & CFO | 7,21k | 0,00 | Derivative Exercise and Retained Stock | - | 160,36k | 4,71% |
| 2026-03-11 | Mr. James F. ClearyExec. VP & CFO | -5,41k | 1,89M | Derivative Exercise and Sale | 350,30 | 160,36k | - |
| 2026-02-20 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 1,03M | Derivative Exercise and Sale | 86,09 - 358,94 | 65,39k | - |
| 2026-02-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 479,16k | Vente | 359,46 | 65,39k | -2,00% |
| 2026-01-20 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 1,01M | Derivative Exercise and Sale | 86,09 - 354,73 | 66,73k | - |
| 2026-01-20 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 472,86k | Vente | 354,73 | 66,73k | -1,96% |
| 2025-12-19 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -1,68k | 578,57k | Vente | 345,00 | 18,80k | -8,19% |
| 2025-12-19 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -3,35k | 1,15M | Vente | 342,10 | 23,89k | -12,30% |
| 2025-12-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 968,45k | Derivative Exercise and Sale | 86,09 - 343,45 | 68,06k | - |
| 2025-12-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 457,82k | Vente | 343,45 | 68,06k | -1,92% |
| 2025-12-17 | Dr. Robert P. MauchPresident, CEO & Director | -3,00k | 0,00 | Other Disposition | - | 66,39k | -4,32% |
| 2025-12-17 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -4,03k | 1,38M | Vente | 343,24 | 17,15k | -19,03% |
| 2025-12-17 | Mr. James F. ClearyExec. VP & CFO | 18,20k | 1,57M | Derivative Exercise and Retained Stock | 86,09 | 153,14k | 13,49% |
| 2025-12-17 | Mr. James F. ClearyExec. VP & CFO | -26,95k | 6,96M | Derivative Exercise and Sale | 86,09 - 344,15 | 153,14k | - |
| 2025-12-17 | Mr. Dennis M. NallyIndependent Director | -1,17k | 0,00 | Other Disposition | - | 11,52k | -9,24% |
| 2025-12-15 | Dr. Robert P. MauchPresident, CEO & Director | -638,00 | 223,50k | Derivative Exercise and Sale | 350,32 | 69,39k | - |
| 2025-12-15 | Mr. James F. ClearyExec. VP & CFO | -199,00 | 69,71k | Derivative Exercise and Sale | 350,32 | 134,94k | - |
| 2025-12-15 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -91,00 | 31,88k | Derivative Exercise and Sale | 350,32 | 21,19k | - |
| 2025-11-20 | Dr. Robert P. MauchPresident, CEO & Director | 3,65k | 0,00 | Derivative Exercise and Retained Stock | - | 69,39k | 5,55% |
| 2025-11-20 | Dr. Robert P. MauchPresident, CEO & Director | -2,14k | 776,28k | Derivative Exercise and Sale | 362,07 | 69,39k | - |
| 2025-11-20 | Mr. James F. ClearyExec. VP & CFO | 1,05k | 0,00 | Derivative Exercise and Retained Stock | - | 134,94k | 0,79% |
| 2025-11-20 | Mr. James F. ClearyExec. VP & CFO | -824,00 | 298,35k | Derivative Exercise and Sale | 362,07 | 134,94k | - |
| 2025-11-20 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | 854,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,24k | 3,24% |
| 2025-11-20 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -736,00 | 266,48k | Derivative Exercise and Sale | 362,07 | 27,24k | - |
| 2025-11-20 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | 602,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,19k | 2,92% |
| 2025-11-20 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -421,00 | 152,43k | Derivative Exercise and Sale | 362,07 | 21,19k | - |
| 2025-11-20 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | 964,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,15k | 23,04% |
| 2025-11-20 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | -1,01k | 365,69k | Derivative Exercise and Sale | 362,07 | 5,15k | - |
| 2025-11-20 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | 526,00 | 0,00 | Derivative Exercise and Retained Stock | - | 20,47k | 2,64% |
| 2025-11-20 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -406,00 | 147,00k | Derivative Exercise and Sale | 362,07 | 20,47k | - |
| 2025-11-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 1,06M | Derivative Exercise and Sale | 86,09 - 366,64 | 65,75k | - |
| 2025-11-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 488,73k | Automatic Disposition | 366,64 | 65,75k | -1,99% |
| 2025-11-13 | Dr. Robert P. MauchPresident, CEO & Director | -18,68k | 5,84M | Sale to Issuer | 312,53 | 67,08k | -21,78% |
| 2025-11-13 | Mr. James F. ClearyExec. VP & CFO | -13,90k | 4,34M | Sale to Issuer | 312,53 | 133,89k | -9,41% |
| 2025-11-13 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -9,53k | 2,98M | Sale to Issuer | 312,53 | 26,39k | -26,54% |
| 2025-11-13 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -1,06k | 330,97k | Sale to Issuer | 312,53 | 20,58k | -4,89% |
| 2025-11-13 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -5,61k | 1,75M | Sale to Issuer | 312,53 | 19,95k | -21,96% |
| 2025-11-07 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 12,67k | 11,68% |
| 2025-11-07 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -1,02k | 369,36k | Derivative Exercise and Sale | 360,70 | 12,67k | - |
| 2025-11-07 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | 2,48k | 0,00 | Derivative Exercise and Retained Stock | - | 15,31k | 19,36% |
| 2025-11-07 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -1,37k | 494,16k | Derivative Exercise and Sale | 360,70 | 15,31k | - |
| 2025-11-07 | Mr. James F. ClearyExec. VP & CFO | 3,44k | 0,00 | Derivative Exercise and Retained Stock | - | 117,73k | 3,01% |
| 2025-11-07 | Mr. James F. ClearyExec. VP & CFO | -1,96k | 705,17k | Derivative Exercise and Sale | 360,70 | 117,73k | - |
| 2025-11-07 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | 2,05k | 0,00 | Derivative Exercise and Retained Stock | - | 19,21k | 11,97% |
| 2025-11-07 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -777,00 | 280,26k | Derivative Exercise and Sale | 360,70 | 19,21k | - |
| 2025-11-07 | Dr. Robert P. MauchPresident, CEO & Director | 4,87k | 0,00 | Derivative Exercise and Retained Stock | - | 42,81k | 12,84% |
| 2025-11-07 | Dr. Robert P. MauchPresident, CEO & Director | -3,41k | 1,23M | Derivative Exercise and Sale | 360,70 | 42,81k | - |
| 2025-10-31 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | 4,17k | 1,41M | Derivative Exercise and Retained Stock | 337,81 | 4,18k | 29 785,71% |
| 2025-10-31 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | -4,37k | 0,00 | Derivative Exercise and Sale | 337,81 | 4,18k | - |
| 2025-10-20 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 905,79k | Derivative Exercise and Sale | 86,09 - 326,80 | 37,94k | - |
| 2025-10-20 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 435,95k | Automatic Disposition | 326,80 | 37,94k | -3,40% |
| 2025-10-01 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -1,89k | 590,85k | Automatic Disposition | 313,28 | 12,82k | -12,82% |
| 2025-09-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 767,31k | Derivative Exercise and Sale | 86,09 - 290,00 | 39,27k | - |
| 2025-09-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 386,86k | Automatic Disposition | 290,00 | 39,27k | -3,29% |
| 2025-09-16 | Mr. Steven H. CollisInitié | -29,35k | 5,98M | Derivative Exercise and Sale | 86,09 - 289,86 | 305,91k | - |
| 2025-09-16 | Mr. Steven H. CollisInitié | -2,00k | 579,72k | Automatic Disposition | 289,86 | 305,91k | -0,65% |
| 2025-08-19 | Mr. Steven H. CollisInitié | -12,58k | 2,56M | Derivative Exercise and Sale | 86,09 - 289,98 | 307,91k | - |
| 2025-08-19 | Mr. Steven H. CollisInitié | -2,00k | 579,96k | Automatic Disposition | 289,98 | 307,91k | -0,65% |
| 2025-08-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,23k | 668,99k | Derivative Exercise and Sale | 86,09 - 293,53 | 40,61k | - |
| 2025-08-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,74k | 511,62k | Automatic Disposition | 293,53 | 40,61k | -4,12% |
| 2025-07-22 | Mr. Steven H. CollisInitié | -12,58k | 2,60M | Derivative Exercise and Sale | 86,09 - 292,67 | 309,91k | - |
| 2025-07-22 | Mr. Steven H. CollisInitié | -2,00k | 585,34k | Automatic Disposition | 292,67 | 309,91k | -0,64% |
| 2025-07-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,23k | 670,86k | Derivative Exercise and Sale | 86,09 - 294,11 | 42,35k | - |
| 2025-07-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,74k | 512,63k | Automatic Disposition | 294,11 | 42,35k | -3,95% |
| 2025-06-24 | Mr. Steven H. CollisInitié | -12,58k | 2,60M | Derivative Exercise and Sale | 86,09 - 292,62 | 311,91k | - |
| 2025-06-24 | Mr. Steven H. CollisInitié | -2,00k | 585,24k | Automatic Disposition | 292,62 | 311,91k | -0,64% |
| 2025-06-18 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -4,08k | 1,21M | Vente | 297,41 | 11,30k | -26,52% |
| 2025-06-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,23k | 674,70k | Derivative Exercise and Sale | 86,09 - 295,30 | 44,09k | - |
| 2025-06-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,74k | 515,00k | Automatic Disposition | 295,30 | 44,09k | -3,80% |
| 2025-06-02 | Walgreens Holding CompanySociété | -765,00k | 0,00 | Vente | - | 9,62M | -7,37% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
